Pharma

WEBINAR: 10 WEEKS TO BREXIT – “NO DEAL” PLANNING: CONTRACTS, DATA PROTECTION, EMPLOYMENT AND INTELLECTUAL PROPERTY

In today’s webinar Paul Butcher, Brexit Director at Herbert Smith Freehills, was joined by Sarah Hawes, Head of Corporate Knowledge,  Miriam Everett, Consultant, Head of Data Protection and Privacy, Anna Henderson, Professional Support Consultant, and Rachel Montagnon, Professional Support Consultant, … Continue reading

Leave a Comment

Filed under Consumer, Contract, Corporate, Data protection, Employment, Intellectual property, Pharma, TMT

Herbert Smith Freehills’ Brexit Legal Guide updated – comparison of IP and pharma provisions in the draft Withdrawal Agreement versus the No Deal provisions promised by the UK Government

The post below was first published on our Intellectual Property blog See the updated IP section of the revised Herbert Smith Freehills Brexit Legal Guide which reviews the IP and pharma elements of the draft Withdrawal Agreement endorsed by the EU Council on … Continue reading

Leave a Comment

Filed under "No Deal" UK papers, Consumer, Intellectual property, Pharma

Five months to Brexit: avoiding a “no deal” crisis

Paul Butcher and Tom Henderson have published an article in FERMA/AIRMIC’s joint Brexit Newsletter advising risk management professionals of some of the key matters that they will need to consider to prevent a Brexit-related “no deal” crisis. Given it remains … Continue reading

Leave a Comment

Filed under Aviation, Capital markets, Competition, Construction, Consumer, Contract, Corporate, Data protection, Disputes, Employment, Energy, Environment, Financial services, Infrastructure, Insolvency, Intellectual property, Manufacturing, Mining, Pharma, Planning, Real estate, Risk & due diligence, State aid, Tax, TMT, Trade, Transport

Brexit “no deal” technical notices published on Patents, Trade marks, Designs, Copyright, GIs, and Exhaustion of rights

The post below was first published on our Intellectual Property blog The latest tranche of “no deal” technical notices was released yesterday afternoon by the UK Government. Amongst them are several notices that highlight the Brexit issues faced by intellectual property right owners and, in … Continue reading

Leave a Comment

Filed under "No Deal" UK papers, Consumer, Intellectual property, Pharma

Brexit “No Deal” Technical Notices – lots for the life sciences sector to think about

The post below was first published on our Intellectual Property blog The UK Government issued the first batch of its Brexit “No Deal” Technical Notices on 23 August 2018. These are designed to provide guidance to businesses and other interested parties on how to … Continue reading

Leave a Comment

Filed under "No Deal" UK papers, Intellectual property, Pharma

EIGHT MONTHS TO BREXIT: IS YOUR BUSINESS PREPARED?

As the clock ticks down to 29 March 2019, the UK and the EU are stepping up their preparations for the possibility of a “no-deal” outcome. From a corporate governance and risk management perspective, businesses that have not done so … Continue reading

Leave a Comment

Filed under ADR, Arbitration, Aviation, Banking & asset management, Capital markets, Competition, Construction, Consumer, Contract, Corporate, Data protection, Development, Disputes, Employment, Energy, Environment, Finance, Financial services, Infrastructure, Insolvency, Insurance, Intellectual property, Manufacturing, Mining, Pharma, Planning, Private wealth, Public international law, Real estate, Risk & due diligence, State aid, Tax, TMT, Trade, Transport, UK-EU negotiations

Intellectual Property and Cyber Security issues considered in UK Government White Paper on the future UK-EU relationship

The post below was first published on our Intellectual Property blog The UK Government’s White Paper detailing its proposal for the future relationship between the UK and the EU (published on 12 July 2018) includes a limited number of proposals relating to … Continue reading

Leave a Comment

Filed under Consumer, Intellectual property, Pharma, UK-EU negotiations

UK Government publishes White Paper on the future UK-EU relationship

The UK Government has today released its White Paper detailing its proposal for the future relationship between the UK and the EU. We will be publishing separately our analysis of the implications of the UK Government’s White Paper, including the … Continue reading

Leave a Comment

Filed under Article 50, Aviation, Capital markets, Competition, Consumer, Data protection, Disputes, Employment, Energy, Environment, Financial services, Intellectual property, Pharma, Public international law, State aid, Tax, TMT, Trade, Transport, UK-EU negotiations

The UK ratifies the Unified Patent Court Agreement on World IP Day

The post below was first published on our Intellectual Property blog The UK has ratified the UPC Agreement today, 26 April 2018, which also happens to be World IP Day. The UK IP Minister announced the ratification at a World IP Day event … Continue reading

Leave a Comment

Filed under Consumer, Intellectual property, Pharma

UK Government agrees elements of the European Commission’s proposals for post-Brexit protection of EU-wide IP rights in the UK in the latest draft of the Withdrawal Agreement

The post below was first published on our Intellectual Property blog In the latest draft of the Withdrawal Agreement (19 March 2018) the UK Government and European Commission negotiators appear to have agreed text providing for the replacement of EU-wide IP rights … Continue reading

Leave a Comment

Filed under Article 50, Consumer, Intellectual property, Pharma, TMT, UK-EU negotiations